KEY FINDINGS
The North America sleep apnea therapeutics and diagnostics market growth is estimated to progress at a CAGR of 6.10% during the forecast period, 2021-2028. The growing demand for portable sleep apnea devices and technological advancements in the sleep apnea devices and platforms propel market growth.
MARKET INSIGHTS
Canada and the United States are assessed for the North America sleep apnea therapeutics and diagnostics market growth analysis. In Canada, the sleep apnea prevalence is moderate. The market growth is attributed to the growing demand for PAP devices. The emerging sleep apnea devices and platforms industry is primarily dependent on conventional sleep apnea devices. However, the unequal access to treatment, partial reimbursement, and lack of funds for research, restrict the technology integration in the sleep apnea devices. Also, the adoption of remote patient assessment devices is hindered due to the exclusion of home sleep testing from reimbursement.
Furthermore, the pandemic impact has negatively impacted the clinical diagnosis of sleep apnea. As per the statement by the Canadian Thoracic Society published on April 2020, clinical visits have been discontinued, available only in the case of an emergency.
COMPETITIVE INSIGHTS
Some of the prominent market players include Invacare Corporation, Cadwell Industries Inc, Smiths Medical Inc, Itamar Medical Ltd, ResMed Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
'
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING AGING POPULATION AND OBESITY
3.1.2. AWARENESS OF ILL EFFECTS OF UNTREATED SLEEP APNEA
3.1.3. SLEEP APNEA INCIDENCES
3.1.4. DEMAND FOR PORTABLE SLEEP APNEA DEVICES
3.1.5. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF SLEEP APNEA DEVICES
3.2.2. LACK OF REIMBURSEMENTS
3.2.3. DEARTH OF PATIENT COMPLIANCE
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. REGULATORY FRAMEWORK
4.5. SUPPLY CHAIN ANALYSIS
4.6. OPPORTUNITY MATRIX
4.7. VENDOR LANDSCAPE
5. MARKET BY PRODUCT TYPE
5.1. THERAPEUTICS
5.1.1. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
5.1.2. OXYGEN DEVICES
5.1.3. MASKS AND ACCESSORIES
5.1.4. ORAL APPLIANCES
5.1.5. ADAPTIVE SERVO VENTILATION (ASV) DEVICES
5.2. DIAGNOSTICS AND MONITORING
5.2.1. POLYSOMNOGRAPHY DEVICE (PSG)
5.2.2. OXIMETER
5.2.3. ACTIGRAPHY MONITORING DEVICE
5.2.4. RESPIRATORY POLYGRAPH
5.2.5. SLEEP APNEA SCREENING DEVICE
5.2.6. OTHER DIAGNOSTICS AND MONITORING DEVICES
6. MARKET BY END-USER
6.1. HOSPITALS & SLEEP LABORATORIES
6.2. HOME CARE SETTINGS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. BMC MEDICAL CO LTD
8.2.2. BRAEBON MEDICAL CORPORATION
8.2.3. CADWELL INDUSTRIES INC
8.2.4. DEVILBISS HEALTHCARE LLC
8.2.5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
8.2.6. GE HEALTHCARE
8.2.7. INVACARE CORPORATION
8.2.8. ITAMAR MEDICAL LTD
8.2.9. KONINKLIJKE PHILIPS NV
8.2.10. MEDTRONIC PLC
8.2.11. NIHON KOHDEN CORPORATION
8.2.12. RESMED INC
8.2.13. SMITHS MEDICAL INC
8.2.14. SOMNOMEDICS GMBH
8.2.15. TELEFLEX INCORPORATED
8.2.16. VYAIRE MEDICAL INC
1. BMC MEDICAL CO LTD
2. BRAEBON MEDICAL CORPORATION
3. CADWELL INDUSTRIES INC
4. DEVILBISS HEALTHCARE LLC
5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
6. GE HEALTHCARE
7. INVACARE CORPORATION
8. ITAMAR MEDICAL LTD
9. KONINKLIJKE PHILIPS NV
10. MEDTRONIC PLC
11. NIHON KOHDEN CORPORATION
12. RESMED INC
13. SMITHS MEDICAL INC
14. SOMNOMEDICS GMBH
15. TELEFLEX INCORPORATED
16. VYAIRE MEDICAL INC
